300 related articles for article (PubMed ID: 21494549)
21. Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes.
Zhu-Mauldin X; Marsh SA; Zou L; Marchase RB; Chatham JC
J Biol Chem; 2012 Nov; 287(46):39094-106. PubMed ID: 22992728
[TBL] [Abstract][Full Text] [Related]
22. Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.
Vigetti D; Deleonibus S; Moretto P; Karousou E; Viola M; Bartolini B; Hascall VC; Tammi M; De Luca G; Passi A
J Biol Chem; 2012 Oct; 287(42):35544-35555. PubMed ID: 22887999
[TBL] [Abstract][Full Text] [Related]
23. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
24. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
25. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
Lam C; Low JY; Tran PT; Wang H
Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
[TBL] [Abstract][Full Text] [Related]
26. Neutrophils exhibit rapid agonist-induced increases in protein-associated O-GlcNAc.
Kneass ZT; Marchase RB
J Biol Chem; 2004 Oct; 279(44):45759-65. PubMed ID: 15322139
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Itano N; Iwamoto S
Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
[TBL] [Abstract][Full Text] [Related]
28. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP
Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of O-GlcNAc modifications derived from streptozotocin and glucosamine induced beta-cell apoptosis.
Park J; Kwon H; Kang Y; Kim Y
J Biochem Mol Biol; 2007 Nov; 40(6):1058-68. PubMed ID: 18047804
[TBL] [Abstract][Full Text] [Related]
30. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Packer M
Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
[TBL] [Abstract][Full Text] [Related]
31. A novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on (13)C mass isotopologue profiles under non-steady-state conditions.
Moseley HN; Lane AN; Belshoff AC; Higashi RM; Fan TW
BMC Biol; 2011 May; 9():37. PubMed ID: 21627825
[TBL] [Abstract][Full Text] [Related]
32. Efficient chemoenzymatic synthesis of uridine 5'-diphosphate N-acetylglucosamine and uridine 5'-diphosphate N-trifluoacetyl glucosamine with three recombinant enzymes.
Li X; Qi C; Wei P; Huang L; Cai J; Xu Z
Prep Biochem Biotechnol; 2017 Oct; 47(9):852-859. PubMed ID: 27220687
[TBL] [Abstract][Full Text] [Related]
33. Protein O-GlcNAcylation impairment caused by N-acetylglucosamine phosphate mutase deficiency leads to growth variations in Arabidopsis thaliana.
Jia X; Zhang H; Qin H; Li K; Liu X; Wang W; Ye M; Yin H
Plant J; 2023 May; 114(3):613-635. PubMed ID: 36799458
[TBL] [Abstract][Full Text] [Related]
34. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Saeui CT; Shah SR; Fernandez-Gil BI; Zhang C; Agatemor C; Dammen-Brower K; Mathew MP; Buettner M; Gowda P; Khare P; Otamendi-Lopez A; Yang S; Zhang H; Le A; Quinoñes-Hinojosa A; Yarema KJ
ACS Chem Biol; 2023 Jan; 18(1):151-165. PubMed ID: 36626752
[TBL] [Abstract][Full Text] [Related]
35. Chronic ingestion of a Western diet increases O-linked-β-N-acetylglucosamine (O-GlcNAc) protein modification in the rat heart.
Medford HM; Chatham JC; Marsh SA
Life Sci; 2012 Jun; 90(23-24):883-8. PubMed ID: 22575823
[TBL] [Abstract][Full Text] [Related]
36. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
37. Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.
McLarty JL; Marsh SA; Chatham JC
Life Sci; 2013 Mar; 92(11):621-7. PubMed ID: 22985933
[TBL] [Abstract][Full Text] [Related]
38. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells.
Luo B; Soesanto Y; McClain DA
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):651-7. PubMed ID: 18174452
[TBL] [Abstract][Full Text] [Related]
39. Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling.
Cui YL; Xue RQ; Xi He ; Ming Zhao ; Yu XJ; Liu LZ; Wu Q; Si Yang ; Li DL; Zang WJ
Life Sci; 2019 Apr; 222():1-12. PubMed ID: 30786250
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
